Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-19T18:31:27.155Z Has data issue: false hasContentIssue false

Beware the problems of centralisation. Commentary on … Mental health research system in England

Published online by Cambridge University Press:  02 January 2018

Paul Lelliott*
Affiliation:
Royal College of Psychiatrists' Research Unit, Standon House, 21 Mansell Street, London E1 8AA, e-mail: [email protected]
Rights & Permissions [Opens in a new window]

Extract

It is difficult to disagree with Chilvers & Clark that, overall, recent work to bring a more systematic approach to the organisation of mental health research in England has been a good thing. It is also necessary if mental health is to compete for research funding with other branches of healthcare. However, recent changes in the research system have not all been positive and there is a danger that the process of centralisation, which is inherent to the model they describe, will have unintended adverse consequences.

Type
Opinion & debate
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 2005

It is difficult to disagree with Chilvers & Clark that, overall, recent work to bring a more systematic approach to the organisation of mental health research in England has been a good thing. It is also necessary if mental health is to compete for research funding with other branches of healthcare. However, recent changes in the research system have not all been positive and there is a danger that the process of centralisation, which is inherent to the model they describe, will have unintended adverse consequences.

Chilvers & Clark acknowledge that ‘the UK has a strong reputation for outputs from mental health research’ compared with other industrialised countries. This reputation was gained under the ‘ laissez-faire approach to R&D’ that Chilvers & Clark argue has prevailed for the past 40 years. This suggests that there were some good things about the old system; care must be taken that the baby is not thrown out with the bath water.

The problems, real and potential, are discussed below.

The stifling of research by bureaucracy

This has been most apparent in three areas: (a) the overcomplex process for obtaining ethical approval for multicentre studies (Reference AlbertiAlberti, 2000; Reference WaldWald, 2004; Department of Health, 2005); (b) cumbersome, diverse and slow procedures for obtaining agreement from local research governance committees for research to be conducted in National Health Service trusts; and (c) the detailed and varied reporting requirements of the system for allocating support for science funding. Far from these changes achieving the Department of Health’s stated intention to ‘minimise bureaucratic process and facilitate high quality research’ (Department of Health, 2004), it has made multicentre health services research very difficult to conduct, discouraged local small-scale research and led to a high proportion of the support for science funding, allocated to non-academic trusts, being spent on managing the bureaucracy of accounting for that funding.

Although changes in research ethics and governance procedures were partly in response to the need to implement the EU Clinical Trials Directive (European Parliament and Council, 2001), the way this has been handled in England is the product of the centralisation of the ‘stewardship’ of research. For example, the current Standard Operating Procedures for Research Ethics Committees, issued by the Central Office for Research Ethics Committees, runs to 219 pages (National Patient Safety Agency, 2005).

The narrowing of decision-making about research priorities

The changes described by Chilvers & Clark will inevitably result in existing and new research funding being channelled more into priorities set by the Department of Health and academics. Although this is understandable, it can only be at the expense of those priorities identified by people working at the coalface of mental healthcare.

The suppression of innovation

Chilvers & Clark state that ‘we need to find ways of ensuring that the innovative research of the future is supported’. However, a more centralised system for setting priorities and allocating funding will not naturally achieve this. Presumably, the new system will not include frequent calls for ‘responsive funding’ bids for grants to support studies on topics chosen by an individual research team.

The creation of cartels

The greatly increased cost of obtaining research ethics and governance approval for multicentre studies works in favour of research institutions with substantial administrative infrastructure. Also, the mental health research network and its hubs will favour the academic institutions involved in their management. Although this is good in that it creates collaborations that can compete on a more equal footing with other medical specialties, it is important that it does not lead to a reduction in competition for research grants; particularly for the larger scale studies that might consume a higher proportion of future funding.

Conclusion

The future health of mental health research in England depends on ensuring that the potential benefits of rationalisation and centralisation are realised and the pitfalls avoided.

References

Alberti, K. G. (2000) Multicentre research ethics committees: has the cure been worse than the disease? No, but idiosyncracies and obstructions to good must be removed. BMJ, 320, 11571158.CrossRefGoogle Scholar
Department of Health (2004) Research Governance in Health and Social Care – NHS Permission for R&D Involving NHS Patients. London: Department of Health. http://www.dh.gov.uk/assetRoot/04/07/58/22/04075822.doc Google Scholar
Department of Health (2005) Report of the Ad Hoc Advisory Group on the Operation of NHS Research Ethics Committees. London: Department of Health.Google Scholar
European Parliament and Council (2001) Directive 2001/20/EC. Luxembourg: European Parliament and Council.Google Scholar
National Patient Safety Agency (2005) Standard Operating Procedures for Research Ethics Committees. London: Central Office for Research Ethics Committees. http://www.corec.org.uk/recs/index.htm Google Scholar
Wald, D. S. (2004) Bureaucracy of ethics applications. BMJ, 329, 282284.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.